治疗方案使用胺和胺对抑郁症的疾病:一个系统的审查
Julia M K Freind1, Fernando R Beserra1, Bruno S Menezes2
1Department of Psychology, Pontifical Catholic University of Rio de Janeiro (PUC-Rio), Rio de janeiro, Brazil.
Journal of psychoactive drugs
|August 28, 2023
概括
胺类药物和胺类药物提供了新的抑郁症治疗方法,但协议有很大差异. 目前的研究强调了一种医学方法,对胺胺辅助心理治疗和心理社会支持的探索有限.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 药理学 药理学是指药理学的学科.
- 心理健康研究 心理健康研究
背景情况:
- 抑郁症是全球领先的心理健康问题,患病率和死亡率很高.
- 胺和胺等分裂性物质正在成为抑郁症疾病的新疗法选择.
- 现有的抑郁症治疗模式需要不断的创新和评估.
研究的目的:
- 系统地审查和分析目前使用胺和胺的抑郁症治疗方案.
- 在研究中比较方法,治疗方法和临床环境.
- 为了识别对胺/胺辅助治疗抑郁症的理解上的差距.
主要方法:
- 系统的文献审查遵循PRISMA指南.
- 在PubMed和Web of Science数据库中进行的搜索.
- 研究程序的比较分析,包括样本特征,治疗模型,临床团队,医疗协议,设置细节和药物管理特点 (胺/胺,路线,剂量).
主要成果:
- 在审查的研究中观察到一种主要的医疗方法.
- 有限的研究存在于胺辅助心理治疗 (KAP) 和其他迷幻辅助疗法.
- 关于关键的心理社会要素,如患者准备,会议支持和会议后的整合,发现信息不足.
结论:
- 与传统的迷幻药辅助疗法相比,在抑郁症管理中,胺和胺的治疗方案显示出相当大的差异.
- 需要进一步研究心理治疗和心理社会支持在胺/胺治疗框架中的整合.
- 未来的研究应该探索标准化但灵活的协议,包括药理和心理干预,以获得最佳的抑郁症治疗结果.
相关概念视频
01:30Electroconvulsive Therapy
68
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
68
01:23Antidepressant Drugs: MAOIs and Other Agents
270
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
270
01:28Drug Therapy
68
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
68
01:25Antidepressant Drugs: Overview
557
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
557
01:26Psychosis: Goals of Pharmacotherapy
165
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
165
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
200
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
200